Multiple sclerosis (MS) is a disease that causes a multitude of symptoms: visual disturbances, weakness, spasticity, walking impairment, balance and coordination disorders, tremor/ataxia, bladder and bowel disorders. Furthermore, “invisible” symptoms such as fatigue, depression, and cognitive dysfunction are also well represented. In parallel with the advances of pharmacological treatments, MS needs an effective comprehensive, multidisciplinary treatment, which is at the basis of the concept of rehabilitation. Moreover, rehabilitation in MS is also responsible of facilitating reorganising mechanism within the CNS.
The 2023 ECTRIMS Summer School – organised together with Rehabilitation in MS (RIMS) – gathered international experts in the field to provide a “state of the art” update on: biological and ecological implications of rehabilitation, how measuring MS with a set of outcome measures and devices is relevant to plan a personalised rehabilitation treatment; how the use of technology in rehabilitation could be useful to improve its effectiveness and a view on the “around the corner” technologies that will be applied in rehab. Finally, the last session was dedicated to the advancements on the design of clinical trial in rehab, taking into account, in particular, the use of digital markers. All the theoretical sessions were followed by practical and interactive working groups that involved all participants in apply the concepts on outcome measure, technologies in rehab and clinical trials in rehabilitation.
The target audience was represented by young neurologists, physiatrists, physical therapists, occupational therapists, and psychologists with interest in this area who want to deepen and implement their expertise in the field.